JNJ

Johnson & Johnson

JNJ · Salud · Next earnings: 13 Oct 2026 · Before the open · Q3 2026

Relevance 40/100 · Minor

1-year price history

Source: Yahoo Finance
- Calculating change...

The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.

Company

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech.

What the market expects

ConsensusPrior-year EPS
EPS2.482.80
Revenue25,313,052,920—

8 analysts

How expectations have moved

Expectations: High

Expectativas elevadas: el consenso de BPA se ha revisado al alza un 2.3% en 30 días y cotiza a un 5% de su máximo de 52 semanas. Superar el consenso no garantiza una subida — el mercado puede tener ya descontado un buen resultado.

Stock, 90 days
+5.3%

Prior behaviour

Average absolute move
0.9%
Largest move
2.7%
releases with a move larger than 5%
0%
beat the EPS consensus in
4 of the last 4
Quarter Date 1-session move Surprise EPS
Jun 2026 15 Jul 2026 -2.7% +2.1%
Mar 2026 14 Apr 2026 +0.9% +1.1%
Dec 2025 21 Jan 2026 -0.1% +1.2%
Sep 2025 14 Oct 2025 -0.0% +1.1%

Historical moves describe typical magnitude, not a future direction.

Expected move

±4.9% (options)

“±X%” is the typical move size, not a forecast of direction.

Stock situation

Price
267.57
30 days
-0.2%
90 days
+5.3%
Distance to 52-week high
-4.8%
Market cap
655,371,930,000

Metrics to watch

Relevance breakdown
market_cap
17.4
analyst_coverage
3.2
estimate_revisions
2.5
recent_price_move
0.1
historical_earnings_vol
1.4
sector_importance
4.0
recent_news_coverage
7.0

Disclaimer

Radar Acciones provides information and analysis tools, not personalised investment advice. Consensus and expectations data describe the setup around an event with objective figures; they must never be read as a forecast of direction or price.